Literature DB >> 2227450

Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains.

J E Galán1, K Nakayama, R Curtiss.   

Abstract

The asd mutants of Salmonella typhimurium have an obligate requirement for diaminopimelic acid (DAP) and will undergo lysis in environments deprived of DAP. This has allowed the development of a balanced-lethal system for the expression of heterologous antigens in vaccine strains using vectors containing the wild-type asd gene from Streptococcus mutans and asd mutant Salmonella hosts [Nakayama et al., Biotechnology 6 (1988) 693-697]. We have cloned the asd gene from S. typhimurium, characterized the gene product and used this gene to construct Asd+ expression cloning vectors. In addition we have constructed an asd cassette and a transposon derived from Tn5 that allow the rapid modification of other vectors for use with delta asd vaccine strains of S. typhimurium adding versatility to the Asd+ vector/delta asd host system of plasmid maintenance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227450     DOI: 10.1016/0378-1119(90)90464-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  118 in total

1.  Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.

Authors:  J E Galen; J Nair; J Y Wang; S S Wasserman; M K Tanner; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors.

Authors:  Ho Young Kang; Charles M Dozois; Steven A Tinge; Tae Ho Lee; Roy Curtiss
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

3.  Autotransporter-based antigen display in bacterial ghosts.

Authors:  Anna Hjelm; Bill Söderström; David Vikström; Wouter S P Jong; Joen Luirink; Jan-Willem de Gier
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

4.  A structural basis for the mechanism of aspartate-beta-semialdehyde dehydrogenase from Vibrio cholerae.

Authors:  Julio Blanco; Roger A Moore; Venkataraman Kabaleeswaran; Ronald E Viola
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

5.  Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.

Authors:  E Kozarov; N Miyashita; J Burks; K Cerveny; T A Brown; W P McArthur; A Progulske-Fox
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli.

Authors:  Jung-Joon Min; Hyun-Ju Kim; Jae Hyo Park; Sungmin Moon; Jae Ho Jeong; Yeoung-Jin Hong; Kyoung-Oh Cho; Jong Hee Nam; Nacksung Kim; Young-Kyu Park; Hee-Seung Bom; Joon Haeng Rhee; Hyon E Choy
Journal:  Mol Imaging Biol       Date:  2007-11-10       Impact factor: 3.488

7.  Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.

Authors:  T K Redman; C C Harmon; S M Michalek
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  A live oral recombinant Salmonella enterica serovar typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens.

Authors:  R R Kulkarni; V R Parreira; Y-F Jiang; J F Prescott
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

9.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.

Authors:  S Wu; D W Pascual; J L VanCott; J R McGhee; D R Maneval; M M Levine; D M Hone
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.